Publications
Using the search function, publications can be filtered according to the criteria "Author", "Keyword", "Journal" und "Year". Within the criteria, a link with "and" / "or" is possible.
2019
- SilentMutations (SIM): a tool for analyzing long-range RNA-RNA interactions in viral genomes and structured RNAs.
Desirò D, Hölzer M, Ibrahim B, Marz M
Virus Res 2019, 260, 135-41 - Cell cycle dynamics during diapause entry and exit in an annual killifish revealed by FUCCI technology.
Dolfi L, Ripa R, Antebi A, Valenzano DR, Cellerino A
Evodevo 2019, 10, 29 - TFEB controls vascular development by regulating the proliferation of endothelial cells.
Doronzo G, Astanina E, Corà D, Chiabotto G, Comunanza V, Noghero A, Neri F, Puliafito A, Primo L, Spampanato C, Settembre C, Ballabio A, Camussi G, Oliviero S, Bussolino F
EMBO J 2019, 38(3), e98250 - Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E, Holzer K, Pusch S, Winkler J, Calvisi DF, Eiteneuer E, Herpel E, Goeppert B, Roessler S, Ori A, Schirmacher P, Breuhahn K, Singer S
Cell Commun Signal 2019, 17(1), 159 - A CRISPR Activation Screen Identifies Genes That Protect against Zika Virus Infection.
Dukhovny A, Lamkiewicz K, Chen Q, Fricke M, Jabrane-Ferrat N, Marz M, Jung JU, Sklan EH
J Virol 2019, 93(16) - Shedding light on the presymbiontic phase of C. arietinum.
Farci D, Sanna C, Medda R, Pintus F, Kalaji HM, Kirkpatrick J, Piano D
Plant Physiol Biochem 2019, 143, 224-31 - It is not all about regeneration: planarians striking power to stand starvation.
Felix DA, Gutiérrez-Gutiérrez Ó, Espada L, Thems A, González-Estévez C
Semin Cell Dev Biol 2019, 87, 169-81 - Conservation and divergence of the p53 gene regulatory network between mice and humans.
Fischer M
Oncogene 2019, 38(21), 4095-109 - Global importance of RNA secondary structures in protein coding sequences.
Fricke M, Gerst R, Ibrahim B, Niepmann M, Marz M
Bioinformatics 2019, 35(4), 579-83 - Preclinical Assessment of MEK1/2 Inhibitors for Neurofibromatosis Type 2-Associated Schwannomas Reveal Differences in Efficacy and Drug Resistance Development.
Fuse MA, Dinh CT, Vitte J, Kirkpatrick J, Mindos T, Plati SK, Young JI, Huang J, Carlstedt A, Franco MC, Brnjos K, Nagamoto J, Petrilli A, Copik AJ, Soulakova JN, Bracho O, Yan D, Mittal R, Shen R, Telischi FF, Morrison H, Giovannini M, Liu XZ, Chang LS, Fernandez-Valle C
Neuro-oncol 2019, 21(4), 486-97
